NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,788,542 | -0.2% | 96,098 | -1.1% | 0.07% | +4.2% |
Q2 2023 | $9,806,636 | +9.2% | 97,182 | -0.4% | 0.07% | +4.4% |
Q1 2023 | $8,977,176 | +101314.1% | 97,578 | 0.0% | 0.07% | -1.4% |
Q4 2022 | $8,852 | -99.9% | 97,578 | -0.5% | 0.07% | +11.3% |
Q3 2022 | $7,457,000 | -12.3% | 98,100 | -2.5% | 0.06% | -4.6% |
Q2 2022 | $8,505,000 | -6.0% | 100,614 | -2.4% | 0.06% | +14.0% |
Q1 2022 | $9,044,000 | +0.2% | 103,064 | -0.1% | 0.06% | +3.6% |
Q4 2021 | $9,024,000 | +1.9% | 103,164 | -4.8% | 0.06% | -3.5% |
Q3 2021 | $8,859,000 | -10.6% | 108,323 | -0.3% | 0.06% | -35.2% |
Q2 2021 | $9,911,000 | +4.7% | 108,623 | -1.9% | 0.09% | -3.3% |
Q1 2021 | $9,466,000 | -12.4% | 110,743 | -3.2% | 0.09% | -20.2% |
Q4 2020 | $10,807,000 | +7.8% | 114,443 | -0.8% | 0.11% | +6.5% |
Q3 2020 | $10,028,000 | -20.3% | 115,313 | -19.9% | 0.11% | -24.6% |
Q2 2020 | $12,577,000 | -82.0% | 144,006 | -83.0% | 0.14% | -85.0% |
Q1 2020 | $70,030,000 | -3.4% | 849,361 | +11.0% | 0.95% | +22.8% |
Q4 2019 | $72,480,000 | -20.3% | 765,440 | -26.9% | 0.77% | -23.3% |
Q3 2019 | $90,979,000 | -29.7% | 1,046,938 | -26.2% | 1.01% | -30.1% |
Q2 2019 | $129,452,000 | -14.4% | 1,417,715 | -9.9% | 1.44% | -15.1% |
Q1 2019 | $151,214,000 | -9.4% | 1,572,851 | -19.2% | 1.70% | -16.8% |
Q4 2018 | $166,971,000 | -4.1% | 1,945,819 | -3.7% | 2.04% | +19.1% |
Q3 2018 | $174,059,000 | +14.7% | 2,020,185 | +0.6% | 1.72% | +11.8% |
Q2 2018 | $151,737,000 | +5.5% | 2,008,695 | +12.9% | 1.53% | +3.0% |
Q1 2018 | $143,884,000 | -2.9% | 1,779,647 | +0.9% | 1.49% | +1.4% |
Q4 2017 | $148,156,000 | +3.3% | 1,764,607 | +5.6% | 1.47% | -33.8% |
Q3 2017 | $143,423,000 | +3.1% | 1,670,619 | +0.3% | 2.22% | +1.3% |
Q2 2017 | $139,047,000 | +12.2% | 1,665,837 | +0.1% | 2.19% | +10.3% |
Q1 2017 | $123,921,000 | +4.3% | 1,664,465 | +2.1% | 1.99% | +0.1% |
Q4 2016 | $118,776,000 | +4.3% | 1,630,647 | +13.0% | 1.98% | -2.6% |
Q3 2016 | $113,927,000 | -3.8% | 1,442,850 | +0.5% | 2.04% | -7.8% |
Q2 2016 | $118,459,000 | +17.4% | 1,435,697 | +3.0% | 2.21% | +12.9% |
Q1 2016 | $100,945,000 | -6.7% | 1,393,504 | +10.8% | 1.96% | -10.2% |
Q4 2015 | $108,222,000 | +11.1% | 1,257,808 | +18.7% | 2.18% | +7.8% |
Q3 2015 | $97,411,000 | -5.0% | 1,059,737 | +1.6% | 2.02% | +5.3% |
Q2 2015 | $102,562,000 | +6.9% | 1,042,940 | +7.2% | 1.92% | +0.6% |
Q1 2015 | $95,928,000 | +9.5% | 972,802 | +2.9% | 1.91% | +8.2% |
Q4 2014 | $87,597,000 | +141.1% | 945,352 | +145.0% | 1.77% | +133.6% |
Q3 2014 | $36,327,000 | +1.4% | 385,914 | -2.5% | 0.76% | +8.8% |
Q2 2014 | $35,816,000 | +4.2% | 395,620 | -2.1% | 0.70% | -6.2% |
Q1 2014 | $34,369,000 | -1.1% | 404,245 | -6.5% | 0.74% | -5.5% |
Q4 2013 | $34,750,000 | +0.8% | 432,321 | -3.8% | 0.78% | -5.3% |
Q3 2013 | $34,484,000 | +9.6% | 449,527 | +1.1% | 0.83% | +14.5% |
Q2 2013 | $31,455,000 | – | 444,854 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |